[Production of highly active hyperimmune sera against the foot-and-mouth disease virus].

[Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis]. Genetika (2011) 0.85

Study of Molecular Mechanisms Involved in the Pathogenesis of Immune-Mediated Inflammatory Diseases, using Psoriasis As a Model. Acta Naturae (2009) 0.75

Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis. Int J Biomed Sci (2013) 0.75

[Enzymatic hydrolysate of muscle proteins as the basis for nutrients for cell cultures]. Vopr Virusol (1990) 0.75

[The viability of foot-and-mouth disease virus in air]. Veterinariia (1968) 0.75

[Contralateral donor kidney study for predicting the fate of transplants in the recipient body]. Vestn Khir Im I I Grek (1979) 0.75

[Transplantation of the pancreas in clinical practice (review of the literature)]. Khirurgiia (Mosk) (1987) 0.75

[Reproduction, morphogenesis and immunobiological properties of Aujeszky's disease virus commercially cultured in a suspension of poultry embryo explants]. Vopr Virusol (1978) 0.75

[Polyvalent cultural foot-and-mouth disease vaccine]. Veterinariia (1977) 0.75

[Expression of the FOSL1 gene in psoriasis and atherosclerosis]. Genetika (2010) 0.75

[Means for decreasing the incidence of postoperative tubular necrosis in kidney transplants]. Vestn Khir Im I I Grek (1987) 0.75

[Survival time of foot-and-mouth disease virus in the sewage of biological products factories]. Veterinariia (1969) 0.75

[Expression of bioinformatically identified genes in skin of psoriasis patients]. Genetika (2013) 0.75

[Role of receptor for advanced glycation end-products in pathgenesis of psoriasis]. Mol Biol (Mosk) (2014) 0.75

[The role of non-invasive diagnostics of pulmonary embolism in the optimization of treatment]. Klin Med (Mosk) (2005) 0.75

[Effect of the main disease and anticoagulant therapy on pulmonary artery thromboembolism]. Voen Med Zh (2006) 0.75

[Standardization of the antigen for the complement fixation test in the diagnosis of brucellosis]. Veterinariia (1977) 0.75

[Treatment tactics of patients with pyloroduodenal stenoses]. Khirurgiia (Mosk) (2007) 0.75

[Aerosol disinfection of industrial premises in the manufacturing of biological products]. Veterinariia (1968) 0.75

[Treatment of gastrointestinal hemorrhage in patients following kidney transplant]. Vestn Khir Im I I Grek (1984) 0.75

[Evaluation of the functional adequacy of a kidney transplant in the body of the donor]. Khirurgiia (Mosk) (1984) 0.75

[Comparative study of Aujeszky's disease virus reproduction in a suspension of poultry embryonic cells and tissues (author's transl)]. Vopr Virusol (1976) 0.75

[Effect of blood transfusions on the survival of cadaveric kidney transplants]. Gematol Transfuziol (1988) 0.75

[Problems in obtaining viable donor kidneys for transplantation (review of the literature)]. Khirurgiia (Mosk) (1979) 0.75

[Relation of the survival of kidney transplants to their initial functional integrity]. Vestn Khir Im I I Grek (1980) 0.75

[The calculation and regulation of dust exposure doses to decrease the level of occupational diseases of dust etiology]. Med Tr Prom Ekol (1995) 0.75

[Veterinary service of the USA]. Veterinariia (1980) 0.75

[Genetically predetermined limitation in the use of HaCaT cells that affects their ability to serve as an experimental model of psoriasis]. Genetika (2014) 0.75

[Oxalosis of kidney allotransplant]. Urol Nefrol (Mosk) (1982) 0.75